Introduction
Leishmaniasis (Kala-Azar) - Overview
Leishmaniasis (Kala-Azar) - Therapeutics Development
Leishmaniasis (Kala-Azar) - Therapeutics Assessment
Leishmaniasis (Kala-Azar) - Companies Involved in Therapeutics Development
Leishmaniasis (Kala-Azar) - Drug Profiles
Leishmaniasis (Kala-Azar) - Dormant Projects
Leishmaniasis (Kala-Azar) - Discontinued Products
Leishmaniasis (Kala-Azar) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Leishmaniasis (Kala-Azar), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Universities/Institutes, 2021
Products under Development by Universities/Institutes, 2021 (Contd..1)
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Leishmaniasis (Kala-Azar) - Pipeline by ABIONYX Pharma SA, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Acea Biotech Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Biokawthar Technologies SAS, 2021
Leishmaniasis (Kala-Azar) - Pipeline by BioLingus AG, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Daiichi Sankyo Co Ltd, 2021
Leishmaniasis (Kala-Azar) - Pipeline by DetectoGen Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Eisai Co Ltd, 2021
Leishmaniasis (Kala-Azar) - Pipeline by GlaxoSmithKline Plc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Immune Modulation Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Impetis Biosciences Ltd, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Macrophage Therapeutics Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by ManRos Therapeutics, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Matinas BioPharma Holdings Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by MedC Biopharma Ltd, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Mind Medicine MindMed Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Molecular Targeting Technologies Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Mycosynthetix Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by NanoCliq LLC, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Nanomerics Ltd, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Novartis AG, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Oblita Therapeutics BVBA, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Pai Life Sciences Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Pfizer Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Pharos I&BT Co Ltd, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Rakta Therapeutics Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Satellos Bioscience Inc, 2021
Leishmaniasis (Kala-Azar) - Pipeline by Synstar Japan Co Ltd, 2021
Leishmaniasis (Kala-Azar) - Dormant Projects, 2021
Leishmaniasis (Kala-Azar) - Dormant Projects, 2021 (Contd..1)
Leishmaniasis (Kala-Azar) - Dormant Projects, 2021 (Contd..2)
Leishmaniasis (Kala-Azar) - Discontinued Products, 2021

List of Figures
Number of Products under Development for Leishmaniasis (Kala-Azar), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• ABIONYX Pharma SA
• Acea Biotech Inc
• Biokawthar Technologies SAS
• BioLingus AG
• Daiichi Sankyo Co Ltd
• DetectoGen Inc
• Eisai Co Ltd
• GlaxoSmithKline Plc
• Immune Modulation Inc
• Impetis Biosciences Ltd
• Macrophage Therapeutics Inc
• ManRos Therapeutics
• Matinas BioPharma Holdings Inc
• MedC Biopharma Ltd
• Mind Medicine MindMed Inc
• Molecular Targeting Technologies Inc
• Mycosynthetix Inc
• NanoCliq LLC
• Nanomerics Ltd
• Novartis AG
• Oblita Therapeutics BVBA
• Pai Life Sciences Inc
• Pfizer Inc
• Pharos I&BT Co Ltd
• Rakta Therapeutics Inc
• Satellos Bioscience Inc
• Synstar Japan Co Ltd